Clincosm LogoSign in Get a demo

Renal Cell Carcinoma

Showing 101 - 125 of 513
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ResiduAl Cancer With Liquid Biopsy Evaluation

Recruiting
  • Bladder Carcinoma
  • +14 more
  • Guardant Reveal
  • Redwood City, California
    Redwood City
Sep 7, 2022

Study of Kidney Tumors in Younger Patients

Recruiting
  • Adult Cystic Nephroma
  • +24 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Birmingham, Alabama
  • +247 more
Sep 2, 2022

Urothelial Carcinoma, Renal Cell Carcinoma, Renal Cyst Trial in Oslo (CT)

Completed
  • Urothelial Carcinoma
  • +3 more
  • CT
  • Oslo, Norway
    Oslo University Hospital
Sep 1, 2022

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Renal Cell Carcinoma Trial (Pembrolizumab)

Completed
Has Results
  • Renal Cell Carcinoma
  • Pembrolizumab
  • (no location specified)
Aug 17, 2022

Renal Cell Carcinoma Trial (Pembrolizumab, Axitinib, Sunitinib)

Active, not recruiting
Has Results
  • Renal Cell Carcinoma
  • Pembrolizumab
  • +2 more
  • (no location specified)
Aug 17, 2022

Tumor Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma Trial in Worldwide (XL092, Atezolizumab,

Recruiting
  • Neoplasm Malignant
  • +5 more
  • Duarte, California
  • +55 more
Aug 17, 2022

Pancreatic Adenocarcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma Trial in United Kingdom, United States

Terminated
  • Pancreatic Adenocarcinoma
  • +13 more
  • San Francisco, California
  • +7 more
Aug 17, 2022

Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus

Recruiting
  • Mesothelioma
  • +14 more
  • Los Angeles, California
  • +13 more
Aug 16, 2022

Renal Cell Carcinoma Trial in Macquarie University, Haifa (Belzutifan, Palbociclib)

Recruiting
  • Renal Cell Carcinoma
  • Macquarie University, New South Wales, Australia
  • +1 more
Aug 15, 2022

Epithelial Ovarian Cancer, NSCLC, Renal Cell Carcinoma Trial in Saint Louis, New York (ITIL-306)

Recruiting
  • Epithelial Ovarian Cancer
  • +2 more
  • ITIL-306
  • Saint Louis, Missouri
  • +1 more
Aug 15, 2022

Systemic Treatments in FH-deficient RCC

Recruiting
  • Metabolomics
  • +3 more
  • Sequencing
  • Shanghai, China
    Yunze Xu
Aug 15, 2022

Renal Cell Carcinoma Trial in Houston (Ipilimumab, Nivolumab, Ciforadenant)

Not yet recruiting
  • Renal Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Kidney Cancer, Renal Cell Carcinoma Trial in United States (Ceevra Reveal)

Completed
Has Results
  • Kidney Cancer
  • Renal Cell Carcinoma
  • Ceevra Reveal
  • Santa Monica, California
  • +5 more
Jul 19, 2022

Kidney Cancer, Renal Cell Carcinoma, Unresectable Renal Cell Carcinoma Trial in United States (Talazoparib, Axitinib)

Recruiting
  • Kidney Cancer
  • +3 more
  • Basking Ridge, New Jersey
  • +6 more
Aug 8, 2022

Renal Cell Carcinoma Trial in Sohag (laparoscopic partial nephrectomy)

Not yet recruiting
  • Renal Cell Carcinoma
  • laparoscopic partial nephrectomy
  • Sohag, Egypt
    Sohag University Hospital
Aug 3, 2022

Renal Cell Carcinoma, Ovarian Tumor Trial in Japan, United States (DS-6000a)

Recruiting
  • Renal Cell Carcinoma
  • Ovarian Tumor
  • Lake Mary, Florida
  • +6 more
Aug 2, 2022

NSCLC, Melanoma, Renal Cell Carcinoma Trial in Haifa (BMC128, Nivolumab)

Recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • Haifa, Israel
    Rambam MC
Aug 1, 2022

Renal Cell Carcinoma Trial in Rome (donor FMT, Placebo FMT)

Recruiting
  • Renal Cell Carcinoma
  • donor FMT
  • Placebo FMT
  • Rome, Italy
  • +1 more
Jul 26, 2022

Metastatic Tumor, Advanced Solid Tumor, Renal Cell Carcinoma Trial in Zhengzhou (CD70 CAR-T cells)

Recruiting
  • Metastatic Tumor
  • +4 more
  • CD70 CAR-T cells
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Jul 19, 2022

ccRCC, RCC, Kidney Cancer Trial in United States (MK-3795, Nivolumab, Cabozantinib)

Active, not recruiting
  • ccRCC
  • +4 more
  • Los Angeles, California
  • +24 more
Jul 18, 2022

Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in Grand Rapids, New York, Houston (NGM438, Pembrolizumab)

Recruiting
  • Pancreatic Cancer
  • +15 more
  • Grand Rapids, Michigan
  • +2 more
Jul 18, 2022

Melanoma, NSCLC, Squamous Cell Carcinoma of Head and Neck Trial in United States (GEN-011, IL-2, Fludarabine)

Terminated
  • Melanoma
  • +8 more
  • GEN-011
  • +3 more
  • Gilbert, Arizona
  • +7 more
Jul 13, 2022

Melanoma, Merkel Cell Carcinoma, Unspecified, Renal Cell Carcinoma Trial in Australia, Netherlands, United States

Recruiting
  • Melanoma
  • +3 more
  • 89Zr-Df-Crefmirlimab
  • Little Rock, Arkansas
  • +7 more
Jul 11, 2022

Brain Metastases, Renal Cell Carcinoma Trial in Houston (Nivolumab, Ipilimumab, Cabozantinib)

Not yet recruiting
  • Brain Metastases
  • Renal Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2022